Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Oncology . These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Advanced convergent synthesis for Gefitinib intermediates eliminating chromatography. High-purity API manufacturing solutions for global pharmaceutical supply chains.
Novel preparation method for 4-(1-cyclopropyl-1H-indol-3-yl)-N-phenylpyrimidin-2-amine derivatives offering high purity and scalable industrial application for third-generation EGFR inhibitors.
Novel synthesis of Erlotinib HCl via 3,4-dihydroxybenzaldehyde avoids demethylation steps, offering cost-effective industrial scale-up for pharmaceutical intermediates.
Patent CN102260272B details high-purity Irinotecan synthesis. Eliminates pyridine, improves yield, ensures supply chain reliability for pharmaceutical manufacturers globally.
Advanced synthesis of 3-aminopiperidine-2,6-dione hydrochloride via L-glutamic acid cyclization. Offers superior purity, reduced toxicity, and cost-effective scaling for pharmaceutical supply chains.
Advanced synthesis of Gefitinib intermediates via CN102146060A. Eco-friendly route eliminates halogenating agents, ensuring high purity and cost reduction in API manufacturing.
Patent CN110747489B reveals a novel electroreduction method for 2-amino-4-methoxybenzoic acid derivatives, offering high-purity intermediates for Gefitinib with reduced environmental impact.
Patent CN113563305B reveals a cost-effective, high-yield route for 2-(4-phenoxyphenyl)-6-(N-substituted oxycarbonyl piperidine-4-) nicotinamide, ensuring reliable supply chain stability.
Efficient Cu(OTf)2 catalyzed synthesis of quinazoline-4-amines via green one-pot tandem reaction. Reliable API intermediate supplier offering cost reduction.
Patent CN119775203B reveals cost-effective synthesis for Capmatinib intermediates. Enhance supply chain reliability and reduce manufacturing costs significantly.
Patent CN112469711A reveals a high-purity synthesis route for quinoline derivatives, eliminating column chromatography and reducing impurities for scalable API intermediate manufacturing.
Novel preparation method of Bosutinib avoiding hazardous chlorinating agents. Offers cost reduction in API manufacturing and reliable supply chain solutions.
Advanced synthesis of Belinostat intermediate II via safe esterification and HWE reactions. Reduces hazards and costs for HDAC inhibitor manufacturing.
Patent CN103864878A reveals a novel cross-coupling method for Abiraterone Acetate using organozinc reagents, offering significant cost reduction and improved purity for pharmaceutical intermediates manufacturing.
Patent CN113024518A details a streamlined 3-step halogenation route for Erdafitinib, offering high purity and reduced costs for pharmaceutical manufacturers.
Patent CN114232013B reveals a metal-free electrochemical route for indoloquinolines. Discover cost-effective, green manufacturing solutions for high-purity pharmaceutical intermediates.
Optimized synthesis of 2-(4-ethyl-3-iodophenyl)-2-methylpropanoic acid via copper catalysis. Reduces heavy metal residue and cost for API manufacturing.
Patent CN115850240B reveals a two-step route for Olutasidenib. This method ensures high purity and supply chain stability for pharmaceutical manufacturers.
Patent CN100564365C details a streamlined 2-step synthesis for Anastrozole, offering superior purity and cost efficiency for pharmaceutical manufacturing.
Patent CN104447739B details deuterated Palbociclib derivatives enhancing bioavailability. We offer scalable synthesis for reliable API intermediate supply chains.